 |
Important Update: Viracor-IBT Laboratories Acquires Assets of Cylex™, Effective February 8, 2013
A note from Thomas W. Burnell, PhD, President and CEO of Viracor-IBT Laboratories:
“As a leader in molecular and immunodiagnostics, Viracor-IBT has been proud to offer the ImmuKnow® assay to its clients for nearly a decade to assist clinicians in making critical decisions for patients undergoing transplants through the use of specialized diagnostics and the accelerated delivery of information. We’re confident this acquisition will result in continued benefits to the industry, our clients and to the patients we serve. Throughout the transition, Viracor-IBT is committed to ensuring continued access to ImmuKnow through the current avenues of kit purchases and laboratory testing.”
Learn more about Viracor-IBT Laboratories.
|
|
Welcome to the Cylex Website
Cylex is a global life sciences company focused on the development, manufacture and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. The Company has developed patented technology that provides an innovative platform to simply and reproducibly assess immune cell function, thus providing crucial insight for individualized transplant patient management.
This patented technology, as part of a global immune status monitoring strategy has been used to help identify kidney, liver, lung and heart transplant patients with low immune response – having the potential to lead to infection. Being in the know gives you crucial insight for individualized patient management.
Our goal is to illuminate immunity to improve health. We do that every day with ImmuKnow®, the only FDA-cleared assay that detects changes in global immune function over time.
This website contains a wealth of information that will enable you to get to know ImmuKnow better. For example, you can learn about ImmuKnow and how it helps clinicians identify transplant patients at risk of infection due to over-immunosuppression by visiting the Health Care Professional section. Or, if you are a patient interested in learning about ImmuKnow and how it provides your doctors with crucial insight for individualized patient management, you can visit the Patients portion of the site. There are many ways to learn about Cylex and ImmuKnow – we invite you to explore them all. |
